Knowledge, Attitudes, and Practices towards Antibiotics, Antimicrobial Resistance, and Antibiotic Consumption in the Population of Kazakhstan

Author:

Semenova Yuliya1ORCID,Kassym Laura1,Kussainova Assiya1,Aimurziyeva Ainur2,Makalkina Larissa3,Avdeyev Andrey4,Yessmagambetova Aizhan5,Smagul Manar6ORCID,Aubakirova Bibigul7,Akhmetova Zaure5,Yergaliyeva Ademi6,Lim Lisa8ORCID

Affiliation:

1. School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan

2. School of Sciences and Humanities, Nazarbayev University, Astana 010000, Kazakhstan

3. Department of Clinical Pharmacology, Astana Medical University, Astana 010000, Kazakhstan

4. Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana 010000, Kazakhstan

5. Ministry of Health of the Republic of Kazakhstan, Astana 010000, Kazakhstan

6. National Center of Public Healthcare, Astana 010000, Kazakhstan

7. WHO Country Office in Kazakhstan, Astana 010000, Kazakhstan

8. Graduate School of Public Policy, Nazarbayev University Astana 010000, Kazakhstan

Abstract

During the COVID-19 pandemic, a ban on inspections of small businesses, including pharmacies, was imposed in Kazakhstan, which relaxed law enforcement efforts regarding the prohibition of over-the-counter antibiotic (AB) sales. This study aimed to investigate how this affected the knowledge, attitudes, and practices (KAP) related to AB and antimicrobial resistance (AMR), as well as to assess actual AB consumption at the community level. The study comprised two cross-sectional sub-studies: the first involved a KAP survey conducted in 2022 and 2024, utilizing the Special Eurobarometer questionnaire on AMR. The second sub-study analyzed AB consumption in 2021 and 2023, measured in defined daily doses per 1000 inhabitants. Results revealed an increase in the percentage of individuals reporting receipt of information about ABs and AMR in the past year (37.3% in 2022 vs. 52.9% in 2024, p < 0.001) and an increase in the percentage of individuals reporting AB use in the past year (49.0% in 2022 vs. 54.0% in 2024, p = 0.056). The most consumed ABs were from the Watch group, with azithromycin and ceftriaxone ranking highest. These findings support the hypothesis that the relaxation of law enforcement contributed to an increase in AB consumption and emphasize the need for public health policies to address this issue.

Funder

Nazarbayev University

Publisher

MDPI AG

Reference25 articles.

1. Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629–655.

2. Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A.A. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11.

3. What is antimicrobial stewardship?;Dyar;Clin. Microbiol. Infect.,2017

4. Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance;Khadse;Cureus,2023

5. Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health;Majumder;Infect. Drug Resist.,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3